You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆汇港股聚焦(06.01)︱中国恒大5月合约销售额达638.6亿元;中国燃气与北京北燃实业集团订立战略合作协议
格隆汇 06-01 23:10

【业绩预告】

永发置业(00287.HK)全年预亏200万至600万港元

阿尔法企业(00948.HK)预期年度亏损大幅减少

【运营数据】

中国恒大(03333.HK)5月合约销售额达638.6亿元

金辉控股(09993.HK):5月合约销售106.6亿元 同比增长38.3%

佳兆业集团(01638.HK):5月合约销售118亿元 按年增加约30.4%

当代置业(01107.HK)5月份合约销售额41.49亿元 同比增长23.87%

合景泰富集团(01813.HK)5月预售额为113.01亿元 同比增加23.5%

【增减持】

都市丽人(02298.HK)获主要股东及主席郑耀南增持305.4万股

建业地产(00832.HK)获控股股东继续增持200万股

华记环球集团(02296.HK)获主席兼控股股东卢卓明购入378.4万股公司普通股及120万份认股权证

昊海生物科技(06826.HK):持股5.26%股东楼国梁拟减持不超216.5万股

阿尔法企业(00948.HK)预期年度亏损大幅减少

并购出售】

廖创兴企业(00194.HK)拟24.8亿泰铢收购泰国苏梅岛东北物业

国银租赁(01606.HK)拟1.298亿美元购买六艘船舶

福晟国际(00627.HK)拟出售香港多处物业

【增发供股】

信阳毛尖(00362.HK)拟先旧后新配股 净筹2920万港元用作营运

【投资运营】

第一服务控股(02107.HK)附属与蜻蜓FM达成战略合作 共同探索音频媒体增值服务

中国生物制药(01177.HK):新型利尿药物“托伐普坦片”获药品注册证书

中国燃气(00384.HK)与北京北燃实业集团订立战略合作协议

Platt Nera(01949.HK)附属拟在泰国成立合营公司 以投资及开发现金存款机项目

海普瑞(09989.HK):全人源单克隆抗体药物(AR-301)III期药品临床试验补充申请获国家药监局批准

再鼎医药-SB(09688.HK)拟携手Mirati Therapeutics在大中华区开发和商业化Adagrasib

永义国际(01218.HK)在拍卖中成功中标漆咸道北大厦

亚博科技(08279.HK)赢得彩票终端机采购招标项目 将向多省供应彩票终端机

蓝河控股(00498.HK)获得保华建业约10%股东投票权的转让

【回购注销】

羚锐制药(600285.SH)截至5月末累计斥资1.55亿元回购2.85%股份

天鸽互动(01980.HK)6月1日耗资294.3万港元回购206.1万股

爪哇控股(00251.HK)6月1日耗资2553.1万港元回购310万股

海尔智家(06690.HK)6月1日耗资3551.50万港元回购111.16万股H股

欢喜传媒(01003.HK)6月1日耗资221.56万港元回购115万股

第一太平(00142.HK)6月1日耗资273.8万港元回购99.6万股

【股权激励】

晶门半导体(02878.HK)授出540万份购股权

利华控股集团(01346.HK)授出640万份购股权

光控精技(03302.HK)6月1日授出1850万份购股权

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account